Promoters I.3 and II are the major promoters directing aromatase expression in breast cancer, and genistein may inhibit the activities of promoters I.3 and II for CYP19 regulation (Chen et al., 1999). The gene discussed is CYP19A1; the disease is breast carcinoma.